secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biohaven Ltd. (BHVN)
CIK:        0001935979
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001935979-24-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biohaven presents at J.P. Morgan Healthcare Conference; pipeline updates expected
--------------------------------------------------------------------------------

- CEO Vlad Coric presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
- Presentation likely covers clinical trial progress for OCD and other pipeline programs.
- No specific financial or clinical data disclosed in the exhibit text provided.
- Form 8-K furnishes the presentation as Exhibit 99.1 under Regulation FD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1935979/000193597924000002/0001935979-24-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1935979/000193597924000002/bhvn-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001935979-24-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer